These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 24029707)
1. Immunohistochemical and molecular characterization of clear cell carcinoma of the lung. Yousem SA Hum Pathol; 2013 Nov; 44(11):2467-74. PubMed ID: 24029707 [TBL] [Abstract][Full Text] [Related]
2. Next-Generation Sequencing of a Cohort of Pulmonary Large Cell Carcinomas Reclassified by World Health Organization 2015 Criteria. Driver BR; Portier BP; Mody DR; Deavers M; Bernicker EH; Kim MP; Teh BS; Santacruz JF; Kopas L; Munden RF; Cagle PT Arch Pathol Lab Med; 2016 Apr; 140(4):312-7. PubMed ID: 26430808 [TBL] [Abstract][Full Text] [Related]
3. [Clinicopathologic features and genetic profile of the redefined large cell lung carcinoma]. Hou LK; Zhang LP; Zhang W; Huang Y; Wu W; Dong ZW; Wu CY Zhonghua Bing Li Xue Za Zhi; 2017 May; 46(5):298-302. PubMed ID: 28468033 [No Abstract] [Full Text] [Related]
4. Pulmonary large cell carcinoma lacking squamous differentiation is clinicopathologically indistinguishable from solid-subtype adenocarcinoma. Hwang DH; Szeto DP; Perry AS; Bruce JL; Sholl LM Arch Pathol Lab Med; 2014 May; 138(5):626-35. PubMed ID: 23738762 [TBL] [Abstract][Full Text] [Related]
5. The ALK translocation in advanced non-small-cell lung carcinomas: preapproval testing experience at a single cancer centre. Conde E; Angulo B; Izquierdo E; Muñoz L; Suárez-Gauthier A; Plaza C; Dominguez N; Torres M; Madrigal L; Rubio-Viqueira B; Belda-Iniesta C; Hidalgo M; López-Ríos F Histopathology; 2013 Mar; 62(4):609-16. PubMed ID: 23379755 [TBL] [Abstract][Full Text] [Related]
6. Suitability of thoracic cytology for new therapeutic paradigms in non-small cell lung carcinoma: high accuracy of tumor subtyping and feasibility of EGFR and KRAS molecular testing. Rekhtman N; Brandt SM; Sigel CS; Friedlander MA; Riely GJ; Travis WD; Zakowski MF; Moreira AL J Thorac Oncol; 2011 Mar; 6(3):451-8. PubMed ID: 21266922 [TBL] [Abstract][Full Text] [Related]
7. The Impact of the Fourth Edition of the WHO Classification of Lung Tumours on Histological Classification of Resected Pulmonary NSCCs. Micke P; Mattsson JS; Djureinovic D; Nodin B; Jirström K; Tran L; Jönsson P; Planck M; Botling J; Brunnström H J Thorac Oncol; 2016 Jun; 11(6):862-72. PubMed ID: 26872818 [TBL] [Abstract][Full Text] [Related]
8. [Relevance of molecular alterations in histopathologic subtyping of lung adenocarcinoma based on 2011 International Multidisciplinary Lung Adenocarcinoma Classification]. Liu B; Shi SS; Wang X; Xu Y; Zhang XH; Yu B; Lu ZF; Wang JD; Zhou XJ Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):505-10. PubMed ID: 23157740 [TBL] [Abstract][Full Text] [Related]
9. Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology. Rossi G; Mengoli MC; Cavazza A; Nicoli D; Barbareschi M; Cantaloni C; Papotti M; Tironi A; Graziano P; Paci M; Stefani A; Migaldi M; Sartori G; Pelosi G Virchows Arch; 2014 Jan; 464(1):61-8. PubMed ID: 24221342 [TBL] [Abstract][Full Text] [Related]
10. Identification of EGFR mutation, KRAS mutation, and ALK gene rearrangement in cytological specimens of primary and metastatic lung adenocarcinoma. Cai G; Wong R; Chhieng D; Levy GH; Gettinger SN; Herbst RS; Puchalski JT; Homer RJ; Hui P Cancer Cytopathol; 2013 Sep; 121(9):500-7. PubMed ID: 23495083 [TBL] [Abstract][Full Text] [Related]
11. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung. Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501 [TBL] [Abstract][Full Text] [Related]
12. A comparison of EGFR and KRAS status in primary lung carcinoma and matched metastases. Monaco SE; Nikiforova MN; Cieply K; Teot LA; Khalbuss WE; Dacic S Hum Pathol; 2010 Jan; 41(1):94-102. PubMed ID: 19740513 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemistry in the differential diagnostics of primary lung cancer: an investigation within the Southern Swedish Lung Cancer Study. Brunnström H; Johansson L; Jirström K; Jönsson M; Jönsson P; Planck M Am J Clin Pathol; 2013 Jul; 140(1):37-46. PubMed ID: 23765532 [TBL] [Abstract][Full Text] [Related]
14. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC). Lim EH; Zhang SL; Li JL; Yap WS; Howe TC; Tan BP; Lee YS; Wong D; Khoo KL; Seto KY; Tan L; Agasthian T; Koong HN; Tam J; Tan C; Caleb M; Chang A; Ng A; Tan P J Thorac Oncol; 2009 Jan; 4(1):12-21. PubMed ID: 19096301 [TBL] [Abstract][Full Text] [Related]
15. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Morita S; Yoshida A; Goto A; Ota S; Tsuta K; Yokozawa K; Asamura H; Nakajima J; Takai D; Mori M; Oka T; Tamaru J; Itoyama S; Furuta K; Fukayama M; Tsuda H Am J Surg Pathol; 2013 Jun; 37(6):924-32. PubMed ID: 23629442 [TBL] [Abstract][Full Text] [Related]
16. Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mackinnon AC; Luevano A; de Araujo LC; Rao N; Le M; Suster S Mod Pathol; 2014 Aug; 27(8):1063-72. PubMed ID: 24390215 [TBL] [Abstract][Full Text] [Related]
17. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients. Yoshizawa A; Sumiyoshi S; Sonobe M; Kobayashi M; Fujimoto M; Kawakami F; Tsuruyama T; Travis WD; Date H; Haga H J Thorac Oncol; 2013 Jan; 8(1):52-61. PubMed ID: 23242438 [TBL] [Abstract][Full Text] [Related]
18. Distinct profile of driver mutations and clinical features in immunomarker-defined subsets of pulmonary large-cell carcinoma. Rekhtman N; Tafe LJ; Chaft JE; Wang L; Arcila ME; Colanta A; Moreira AL; Zakowski MF; Travis WD; Sima CS; Kris MG; Ladanyi M Mod Pathol; 2013 Apr; 26(4):511-22. PubMed ID: 23196793 [TBL] [Abstract][Full Text] [Related]
19. Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. Onozato R; Kosaka T; Kuwano H; Sekido Y; Yatabe Y; Mitsudomi T J Thorac Oncol; 2009 Jan; 4(1):5-11. PubMed ID: 19096300 [TBL] [Abstract][Full Text] [Related]
20. Subtyping of undifferentiated non-small cell carcinomas in bronchial biopsy specimens. Loo PS; Thomas SC; Nicolson MC; Fyfe MN; Kerr KM J Thorac Oncol; 2010 Apr; 5(4):442-7. PubMed ID: 20195168 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]